{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:51:31Z","timestamp":1792601491931,"version":"4.5.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[1997,12,1]],"date-time":"1997-12-01T00:00:00Z","timestamp":880934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1997,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The PARI-IS Study is a double-blind placebo-controlled randomized clinical trial to study the effect of an immunostimulating agent to prevent acute respiratory exacerbation in patients with COPD. Three hundred eighty-one ambulatory patients (190 placebo and 191 immunostimulant) were followed at home for 6 mo by experienced research nurses. The risk of having at least one episode of acute exacerbation (primary outcome) was similar in the two groups (p = 0.872). In contrast, the total number of days of hospitalization for a respiratory problem was 55% less in the group treated with OM-85 BV (287 d) than in the group treated with placebo (642 d). Patients treated with OM-85 BV spent an average of 1.5 d in hospital compared with 3.4 d for patients treated with placebo (p = 0.037). The risk of being hospitalized for a respiratory problem was 30% lower in the treated group (16.2%) than in the placebo group (23.2%); p = 0.089. Eight deaths were observed: two in patients treated with OM-85 BV and six in patients treated with placebo (p = 0.153). During the course of the study dyspnea improved slightly in patients treated with OM-85 BV, whereas it deteriorated slightly in patients receiving placebo (p = 0.028). These results suggest that this immunostimulating agent may be beneficial for patients with COPD by reducing the likelihood of severe respiratory events leading to hospitalization.<\/jats:p>","DOI":"10.1164\/ajrccm.156.6.9612096","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T13:26:37Z","timestamp":1365081997000},"page":"1719-1724","source":"Crossref","is-referenced-by-count":169,"title":["Effects of an Immunostimulating Agent on Acute Exacerbations and Hospitalizations in Patients with Chronic Obstructive Pulmonary Disease"],"prefix":"10.1093","volume":"156","author":[{"given":"J. P.","family":"COLLET","sequence":"first","affiliation":[{"name":"Randomized Clinical Trial Unit, SMBD Jewish General Hospital; Department of Epidemiology and Biostatistics, McGill University; Department of Respirology, Montreal General Hospital; and D\u00e9partement de Pneumologie, H\u00f4pital Notre Dame, Universit\u00e9 de Montr\u00e9al, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"SHAPIRO","sequence":"additional","affiliation":[{"name":"Randomized Clinical Trial Unit, SMBD Jewish General Hospital; Department of Epidemiology and Biostatistics, McGill University; Department of Respirology, Montreal General Hospital; and D\u00e9partement de Pneumologie, H\u00f4pital Notre Dame, Universit\u00e9 de Montr\u00e9al, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"ERNST","sequence":"additional","affiliation":[{"name":"Randomized Clinical Trial Unit, SMBD Jewish General Hospital; Department of Epidemiology and Biostatistics, McGill University; Department of Respirology, Montreal General Hospital; and D\u00e9partement de Pneumologie, H\u00f4pital Notre Dame, Universit\u00e9 de Montr\u00e9al, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"RENZI","sequence":"additional","affiliation":[{"name":"Randomized Clinical Trial Unit, SMBD Jewish General Hospital; Department of Epidemiology and Biostatistics, McGill University; Department of Respirology, Montreal General Hospital; and D\u00e9partement de Pneumologie, H\u00f4pital Notre Dame, Universit\u00e9 de Montr\u00e9al, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"DUCRUET","sequence":"additional","affiliation":[{"name":"Randomized Clinical Trial Unit, SMBD Jewish General Hospital; Department of Epidemiology and Biostatistics, McGill University; Department of Respirology, Montreal General Hospital; and D\u00e9partement de Pneumologie, H\u00f4pital Notre Dame, Universit\u00e9 de Montr\u00e9al, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"ROBINSON","sequence":"additional","affiliation":[{"name":"Randomized Clinical Trial Unit, SMBD Jewish General Hospital; Department of Epidemiology and Biostatistics, McGill University; Department of Respirology, Montreal General Hospital; and D\u00e9partement de Pneumologie, H\u00f4pital Notre Dame, Universit\u00e9 de Montr\u00e9al, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[1997,12,1]]},"reference":[{"key":"2026032709254786100_B1"},{"key":"2026032709254786100_B2"},{"key":"2026032709254786100_B3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0007-0971(87)90107-0","article-title":"Quality of life in patients with chronic airflow limitations.","volume":"81","author":"Guyatt","year":"1987","journal-title":"Br. J. Dis. Chest"},{"key":"2026032709254786100_B4"},{"key":"2026032709254786100_B5"},{"key":"2026032709254786100_B6"},{"key":"2026032709254786100_B7","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1164\/ajrccm\/140.3_Pt_2.S9","article-title":"Trends in COPD morbidity and mortality in the United States.","volume":"140(Suppl.)","author":"Feinleib","year":"1989","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032709254786100_B8","first-page":"328S","article-title":"Chronic airways disease in the United States: trends and determinants.","volume":"96(Suppl.)","author":"Higgins","year":"1989","journal-title":"Chest"},{"key":"2026032709254786100_B9","first-page":"35","article-title":"Epidemiology of COPD.","volume":"85(Suppl.)","author":"Higgins","year":"1984","journal-title":"Chest"},{"key":"2026032709254786100_B10","first-page":"225","article-title":"Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma (ATS statement).","volume":"136","author":"American Thoracic Society","year":"1986","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032709254786100_B11","doi-asserted-by":"crossref","first-page":"196","DOI":"10.7326\/0003-4819-106-2-196","article-title":"Antibiotic therapy in exacerbation of chronic obstructive pulmonary disease.","volume":"106","author":"Anthoninsen","year":"1987","journal-title":"Ann. Intern. Med."},{"key":"2026032709254786100_B12","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0192-0561(89)90149-5","article-title":"Stimulation by a bacterial extract (Broncho-Vaxom) of the metabolic and functional activities of murine macrophages.","volume":"11","author":"Mau\u00ebl","year":"1989","journal-title":"Int. J. Immunopharmacol."},{"key":"2026032709254786100_B13","first-page":"225","article-title":"Multicentre double blind study of the Broncho-Vaxom in chronic bronchitis.","volume":"38","author":"Keller","year":"1984","journal-title":"Prax. Klin. Pneumol."},{"key":"2026032709254786100_B14","first-page":"424","article-title":"A double blind multicentre trial with Broncho-Vaxom in adults.","volume":"9","author":"Ahrens","year":"1983","journal-title":"Atemwegs Lungenkrankeheiten"},{"key":"2026032709254786100_B15","first-page":"289","article-title":"Prevention of respiratory diseases in a large industrial enterprise: double blind study of Broncho-Vaxom.","volume":"9","author":"Geiser","year":"1983","journal-title":"Acta Therap."},{"key":"2026032709254786100_B16","first-page":"143","article-title":"Effect of a bacterial lysate (Broncho-Vaxom) in the treatment of chronic bronchitis: a multicentre double blind clinical trial.","volume":"101","author":"Messerli","year":"1981","journal-title":"Rev. Med. Suisse Romande"},{"key":"2026032709254786100_B17","first-page":"135","article-title":"Clinical effectiveness of Broncho-Vaxom in patients with chronic obstructive pulmonary disease.","volume":"9","author":"Xinogalos","year":"1993","journal-title":"Int. J. Immunother."},{"key":"2026032709254786100_B18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0192-0561(84)90005-5","article-title":"Clinical and immunibiological effects of an orally administered bacterial extract.","volume":"6","author":"Maestroni","year":"1984","journal-title":"Int. J. Immunopharmacol."},{"key":"2026032709254786100_B19","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000195916","article-title":"Immunotherapy with an oral bacterial extract (OM-85 BV) for upper respiratory infections.","volume":"58","author":"Paupe","year":"1991","journal-title":"Respiration"},{"key":"2026032709254786100_B20","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/00006454-199308000-00005","article-title":"Stimulation of nonspecific immunity to reduce the risk of recurrent infections in children attending day-care centers.","volume":"12","author":"Collet","year":"1993","journal-title":"Pediatr. Infect. Dis. J."},{"key":"2026032709254786100_B21"},{"key":"2026032709254786100_B22"},{"key":"2026032709254786100_B23","first-page":"241","article-title":"Dyspnoea, disability and distance walked: comparison of estimates of exercise performance in respiratory disease.","volume":"2","author":"McGavin","year":"1978","journal-title":"B.M.J."},{"issue":"7","key":"2026032709254786100_B24","first-page":"300","article-title":"Secretion of PGE2 on Guinea Pigs Alveolar Macrophages after Treatment with Broncho-Vaxom. International Symposium, Bad Lippspringe, July 26\u201329, 1989.","volume":"12","author":"Fontanges","year":"1989","journal-title":"Allergologie"},{"key":"2026032709254786100_B25"},{"key":"2026032709254786100_B26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/08923978909082140","article-title":"Activation of natural killer cells and cytokine production in man by bacterial extracts.","volume":"11","author":"Wybran","year":"1989","journal-title":"Immunopharm. Immunotox."},{"key":"2026032709254786100_B27"},{"key":"2026032709254786100_B28","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/0192-0561(92)90073-T","article-title":"Upregulation of adhesion molecules induced by Broncho-Vaxom on phagocytic cells.","volume":"14","author":"Duchow","year":"1992","journal-title":"Int. J. Immunopharmacol."},{"key":"2026032709254786100_B29","first-page":"9","article-title":"Animal experiments on the compensation of the immunosuppressive action of cyclophosphamide by a bacterial derivative (Broncho-Vaxom).","volume":"160","author":"Bosch","year":"1981","journal-title":"Immunology"},{"issue":"7","key":"2026032709254786100_B30","first-page":"300","article-title":"Effect of Broncho-Vaxom (BV) on experimental pleuresy model in rate and production of LTB4 and PAF. International Symposium on Mucosal Immunity of the Respiratory Tract, Bad Lippspringe, July 26\u201329, 1989.","volume":"12","author":"Fontanges","year":"1989","journal-title":"Allergologie"},{"key":"2026032709254786100_B31"},{"key":"2026032709254786100_B32","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000194264","article-title":"Immunoglobulin production in man stimulated by an orally administered bacterial lysate.","volume":"40","author":"Puigdollers","year":"1980","journal-title":"Respiration"},{"key":"2026032709254786100_B33","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000195827","article-title":"Local immunity in patients with chronic bronchitis and the effects of a bacterial extract, Broncho-Vaxom, on T-lymphocytes, macrophages, gamma-interferon and secretory immunoglobulin A in bronchoalveolar lavage fluid and other variables.","volume":"57","author":"Emmerich","year":"1990","journal-title":"Respiration"},{"key":"2026032709254786100_B34"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/156\/6\/1719\/67451051\/ajrccm_156_6_1719.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/156\/6\/1719\/67451051\/ajrccm_156_6_1719.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:25:55Z","timestamp":1774617955000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/156\/6\/1719\/8531110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,12,1]]},"references-count":34,"journal-issue":{"issue":"6","published-online":{"date-parts":[[1997,12,1]]},"published-print":{"date-parts":[[1997,12,1]]}},"URL":"https:\/\/doi.org\/10.1164\/ajrccm.156.6.9612096","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1997,12]]},"published":{"date-parts":[[1997,12,1]]}}}